Rohingya Pharmaceuticals cephalosporine capsules approved by the State Drug Administration

recently, Shandong Luoxin Pharmaceutical Group LimitedCompany(http://(hereinafter referred to as "Roxin Pharmaceuticals") cephalosporine capsules were approved by the StatePharmaceutical(http://Regulatory Authority, formally approved by thePharmaceutical(http://consistent evaluation of quality and efficacyAbout cephalosporine capsules
cephalosporine capsules is theproducts approved for market by Luoxin Pharmaceuticals(http://, used for sensitive bacteria caused by acute tonsillitis, pharyngitis, otitis, sinusitis, bronchitis, pneumonia and other respiratory infections, urinary tract infections and skin soft tissue infections, etc, with oral absorption, small toxicity, antimicrobial spectrum of the advantages it is understood that cephalosporine capsules have entered the national list of essential drugs on Luoxin Pharmaceutical as a senior local enterprise sancin (http:// , Luoxin Pharmaceuticals actively respond to the overall requirements of national consistency evaluation, is comprehensively promoting the quality and efficacy of generic drugs consistent evaluation work, committed to the quality and efficacy of similar generic drugs to replace the patent (http:// expired original research drugs, to provide patients with high quality and reasonable price of drugs in addition to the consistent evaluation of the acetic ammonia bromide tablets and cephalosporine capsules, a number of varieties have been carried out consistency evaluation At present, the remaining five products, such as lansolaquine for injection, have completed the declaration of consistency evaluation It is expected that by the end of 2020, nearly 30 varieties will have been declared for the consistency evaluation of generic drugs